Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Cancer and Other Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06580938
What this trial is testing

Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer

Who this might be right for
Non Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more
Pfizer 4
Early research (Phase 1)Ended earlyNCT04244552
What this trial is testing

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+13 more
Atreca, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT07602842
What this trial is testing

IDP-001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more
InduPro, Inc. 132
Early research (Phase 1)Looking for participantsNCT05877599
What this trial is testing

NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Who this might be right for
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more
AstraZeneca 45
Early research (Phase 1)Ended earlyNCT02711345
What this trial is testing

A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers.

Who this might be right for
Ovarian NeoplasmsNon-Small-Cell Lung CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 65
Testing effectiveness (Phase 2)Study completedNCT04256707
What this trial is testing

Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment

Who this might be right for
Non-Small Cell Lung Carcinoma (NSCLC)Colorectal Cancer (CRC)Other Solid Tumors
Karyopharm Therapeutics Inc 126
Testing effectiveness (Phase 2)UnknownNCT05332574
What this trial is testing

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Who this might be right for
NSCLCOther Solid Tumors
Genor Biopharma Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07407933
What this trial is testing

YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Who this might be right for
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd. 118
Testing effectiveness (Phase 2)Looking for participantsNCT05451602
What this trial is testing

HEC169096 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Sunshine Lake Pharma Co., Ltd. 456
Early research (Phase 1)Looking for participantsNCT05983432
What this trial is testing

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Who this might be right for
Non Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more
SystImmune Inc. 540
Testing effectiveness (Phase 2)Looking for participantsNCT05956587
What this trial is testing

SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerNasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT05949619
What this trial is testing

BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 14
Early research (Phase 1)Study completedNCT03468426
What this trial is testing

Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

Who this might be right for
Non-squamous, Non-Small-Cell Lung CancerNeoplasms
Boehringer Ingelheim 252
Testing effectiveness (Phase 2)Looking for participantsNCT05098132
What this trial is testing

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerUntreated Advanced NSCLC+1 more
Synthekine 364
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609
What this trial is testing

Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more
Ascendis Pharma Oncology Division A/S 320
Early research (Phase 1)Study completedNCT01587703
What this trial is testing

Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers

Who this might be right for
Carcinoma, Midline
GlaxoSmithKline 196
Very early researchEnded earlyNCT00253461
What this trial is testing

11C Topotecan PET Imaging

Who this might be right for
Lung CancerMetastatic CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT03565003
What this trial is testing

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 126
Next Page